Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02107378 |
|
Recruitment Status :
Terminated
(sponsor decision)
First Posted : April 8, 2014
Last Update Posted : November 30, 2016
|
Sponsor:
SOTIO a.s.
Information provided by (Responsible Party):
SOTIO Biotech ( SOTIO a.s. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 2016 |
| Actual Study Completion Date : | August 2016 |